I Sendow
Unknown Affiliation

Published : 4 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 4 Documents
Search

The Prospect of Immunoglobulin Y for Therapy of Canine parvovirus Infection in Dogs Suartini, I Gusti Ayu Agung; Sendow, I
WARTAZOA. Indonesian Bulletin of Animal and Veterinary Sciences Vol 25, No 2 (2015): JUNE 2015
Publisher : Indonesian Animal Sciences Society

Show Abstract | Download Original | Original Source | Check in Google Scholar | Full PDF (190.009 KB) | DOI: 10.14334/wartazoa.v25i2.1142

Abstract

Canine parvovirus (CPV) is a highly infectious virus. The virus causes death in dogs worldwide. The mortality rate due to infection of CPV in dog reaches 91%. Prevention of CPV infection in puppies has been done by vaccination which is effectively proven. Protective mechanisms of maternal antibodies contribute to the failure of vaccination. Highly stable characteristics of parvovirus enable the virus still exist in the environment. Various therapies are performed only to suppress the clinical symptoms but can not reduce puppy mortalities. This review discusses CPV alternative therapy and the advantages using immunoglobulin Y (IgY) specific antibodies isolated from chicken egg yolk. Immunoglobulin Y will neutralize the virus, so it can not infect host cells. Intravenous IgY therapy has shown to suppress the spread of CPV infection and prevent death. Key words: Parvovirus, canine, immunotherapy, immunoglobulin Y
Hantavirus: Structure, Mechanism of Transmission of Disease, Development of Drugs and Vaccines, and Prevention in Indonesia Nur Sabiq Assadah; I Sendow; NLP I Dharmayanti
WARTAZOA, Indonesian Bulletin of Animal and Veterinary Sciences Vol 30, No 2 (2020): June 2020
Publisher : Indonesian Center for Animal Research and Development

Show Abstract | Download Original | Original Source | Check in Google Scholar | Full PDF (131.712 KB) | DOI: 10.14334/wartazoa.v30i2.2457

Abstract

Hantavirus is a zoonosis transmitted by rodents and have been spread in various countries. Hantavirus causes Hantavirus Pulmonary Syndrome (HPS) and Haemorrhagic Fever with Renal Syndrome (HFRS) in humans is still receiving worldwide attention due to the high case fatality rate. Epidemiological studies have shown that Hantavirus is widespread globally, including in Indonesia. Indonesia is an archipelago and has a tropical climate, and is crossed by the equator so that it has an enormous diversity of animals, including those that become reservoirs of Hantavirus and other vulnerable animals. The high risk of developing Hantavirus in Indonesia does not rule out the possibility of a Hantavirus outbreak if no preventive action is taken. Until now there is no effective and safe vaccine or treatment for Hantavirus. Various development efforts continue to be made to obtain an appropriate and safe vaccine to prevent and stop the spread of Hantavirus. This paper discusses Hantavirus, including its structure and mechanism of transmission, the current situation of Hantavirus in Indonesia and the efforts that can be made to prevent Hantavirus, including the development of vaccines and their drugs.
Awareness of Ebola: An Exotic Zoonotic Disease NLPI Dharmayanti; I Sendow
WARTAZOA, Indonesian Bulletin of Animal and Veterinary Sciences Vol 25, No 1 (2015): MARCH 2015
Publisher : Indonesian Center for Animal Research and Development

Show Abstract | Download Original | Original Source | Check in Google Scholar | Full PDF (240.843 KB) | DOI: 10.14334/wartazoa.v25i1.1126

Abstract

Filovirus including Ebola and Marburg hemorrhagic fever is a zoonotic disease that characterised by immune suppression and systemic inflammatory response causing impairment of the vascular and immune systems. It is leading to multiorgan failures with mortality varies from 50-90% in human and primate. The Ebola virus is currently divided into five species, namely Zaire ebolavirus (ZEBOV), Sudan ebolavirus (SEBOV), Tai Forest ebolavirus, Reston ebolavirus (REBOV) and Bundibugyo ebolavirus. Geographical distribution of Ebola virus in the Afrotropics region is mainly in the rainforests of Central and West Africa, while REBOV was detected in the Philippines. Bats are suspected as reservoir host of the virus. Recently, Ebola cases had been reported in endemic areas in Africa and then distributed to other countries which was not endemic through human travellers. Ebola virus is also potentially used as a biological weapon, so Ebola virus becomes public health concern. This paper describes the characters of Ebola virus, its clinical signs, transmission and threat as an exotic disease in Indonesia. By understanding the disease, the emergence of Ebola virus in Indonesia can be anticipated quickly. Key words: Ebola virus, exotic, pathogen
The Prospect of Immunoglobulin Y for Therapy of Canine parvovirus Infection in Dogs I Gusti Ayu Agung Suartini; I Sendow
WARTAZOA, Indonesian Bulletin of Animal and Veterinary Sciences Vol 25, No 2 (2015): JUNE 2015
Publisher : Indonesian Center for Animal Research and Development

Show Abstract | Download Original | Original Source | Check in Google Scholar | Full PDF (190.009 KB) | DOI: 10.14334/wartazoa.v25i2.1142

Abstract

Canine parvovirus (CPV) is a highly infectious virus. The virus causes death in dogs worldwide. The mortality rate due to infection of CPV in dog reaches 91%. Prevention of CPV infection in puppies has been done by vaccination which is effectively proven. Protective mechanisms of maternal antibodies contribute to the failure of vaccination. Highly stable characteristics of parvovirus enable the virus still exist in the environment. Various therapies are performed only to suppress the clinical symptoms but can not reduce puppy mortalities. This review discusses CPV alternative therapy and the advantages using immunoglobulin Y (IgY) specific antibodies isolated from chicken egg yolk. Immunoglobulin Y will neutralize the virus, so it can not infect host cells. Intravenous IgY therapy has shown to suppress the spread of CPV infection and prevent death. Key words: Parvovirus, canine, immunotherapy, immunoglobulin Y